Name
Fons Perearstid OÜ
Registry code
10836107
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
16.01.2002 (22)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
440 138 €
64 802 €
15%
2 818 €
(estimate is approximate)
92 880 €
4
Submitted
No tax arrears
70%
49%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Anu Niisuke 12.08.1961 (63) | 50% - 1 278.00 EUR | Board member | Direct ownership | Founder |
| Vello Roosmaa 10.09.1954 (70) | 50% - 1 278.00 EUR | Board member | Direct ownership | Founder |
| 2019 22.07.2020 | 2020 20.06.2021 | 2021 24.06.2022 | 2022 12.06.2023 | 2023 24.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 325 634 € | 309 036 € | 332 295 € | 383 953 € | 440 138 € |
| Net profit (loss) for the period | 45 339 € | 48 293 € | 45 326 € | 61 038 € | 64 802 € |
| Profit Margin | 14% | 16% | 14% | 16% | 15% |
| Current Assets | 63 182 € | 63 716 € | 74 257 € | 96 393 € | 124 824 € |
| Fixed Assets | 14 380 € | 17 341 € | 12 731 € | 11 047 € | 8 426 € |
| Total Assets | 77 562 € | 81 057 € | 86 988 € | 107 440 € | 133 250 € |
| Current Liabilities | 28 240 € | 20 725 € | 29 139 € | 29 363 € | 40 370 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 49 322 € | 60 332 € | 57 849 € | 78 077 € | 92 880 € |
| Employees | 4 | 4 | 4 | 4 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 18 422.41 € | 19 075.17 € | 4 |
| 2023 Q4 | - | 17 646.19 € | 15 463.21 € | 4 |
| 2023 Q3 | - | 28 332.26 € | 22 953.59 € | 4 |
| 2023 Q2 | - | 15 997.62 € | 16 604.02 € | 4 |
| 2023 Q1 | - | 16 401.71 € | 17 036.07 € | 4 |
| 2022 Q4 | - | 21 633.7 € | 16 446.73 € | 4 |
| 2022 Q3 | - | 17 967.51 € | 16 936.57 € | 4 |
| 2022 Q2 | - | 13 550.84 € | 13 845.21 € | 4 |
| 2022 Q1 | - | 14 575.12 € | 13 723.88 € | 4 |
| 2021 Q4 | - | 13 693.37 € | 10 807.08 € | 4 |
| 2021 Q3 | - | 23 227 € | 17 621.21 € | 4 |
| 2021 Q2 | - | 11 735.96 € | 11 867.06 € | 4 |
| 2021 Q1 | - | 12 261.22 € | 12 417.17 € | 4 |
| 2020 Q4 | - | 15 468.11 € | 9 629.57 € | 4 |
| 2020 Q3 | - | 18 027.21 € | 15 780.07 € | 4 |
| 2020 Q2 | - | 11 329.07 € | 11 451.54 € | 4 |
| 2020 Q1 | - | 13 872.06 € | 14 109.67 € | 5 |
